Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-24 @ 9:10 PM
Last Modification Date: 2025-12-24 @ 9:10 PM
Retention: SAMPLES_WITHOUT_DNA
Description: A) Bone turnover markers: We will assess markers of bone formation, including osteocalcin (OC) and procollagen type 1 N-terminal propeptide (P1NP), and a marker of bone resorption, c-telopeptide (CTX).

B) Inflammation: We will assess CRP.

C) In participants with CF, we will assess dysglycemia with a continuous glucose monitor.
Section: A) Bone turnover markers: We will assess markers of bone formation, including osteocalcin (OC) and procollagen type 1 N-terminal propeptide (P1NP), and a marker of bone resorption, c-telopeptide (CTX). B) Inflammation: We will assess CRP. C) In participants with CF, we will assess dysglycemia with a continuous glucose monitor.